Terumo Blood and Cell Technologies specializes in advanced medical technologies that enhance blood and cell-based therapies globally. Their offerings include innovative solutions for blood collection centers, therapeutic apheresis, and cell therapy technologies. The company focuses on improving the efficiency and safety of blood collection and processing through automation and pathogen reduction technologies. For instance, their Trima Accel® Automated Blood Collection System and Mirasol® Pathogen Reduction Technology System are designed to optimize the collection process while ensuring the safety of blood products. These technologies not only streamline operations but also help healthcare providers meet the growing demand for blood and cell therapies, particularly in the face of evolving healthcare challenges.

In addition to their core technologies, Terumo Blood and Cell Technologies emphasizes the importance of data and operational oversight in blood centers. Their TOMEs software integrates with various devices to enhance decision-making and operational efficiency, allowing blood centers to better manage their resources and improve donor experiences. By leveraging automation and comprehensive software solutions, the company aims to support blood centers in navigating the complexities of modern healthcare, ultimately enhancing patient care and access to vital blood and cell-based treatments.

United States

Headquartered in Lakewood, Colorado, Terumo Blood and Cell Technologies provides blood component, therapeutic apheresis and cellular technologies serving customers in more than 130 countries.

Terumo Blood and Cell Technologies

Company Details